Overview

Immune Repertoire Sequencing Market Introduction Immune repertoire sequencing market is forecasted to value over US$ 175 Million by 2027 end and register a CAGR of over 7.5% from 2020 to 2027.

Human adaptive immune system protection is brought to the surface of B-cell receptor (BCR) and T-cell receptor(TCR) by receptors. Advancements in next-generation sequencing (NGS) have allowed the birth of new technology in the form of immune repertoire sequencing. It delves in determining the region of the receptors. It helps in delivering information regarding the antigen-specific present within lymphocytes. Increasing support from government regarding pharmacogenomics-based drug recovery has boosted the growth of the market. The rapid increase in multiple therapeutic areas like pain management, infectious diseases, cardiology, and oncology is stimulating the size of the market as well. In addition, various organizations aiming to look for solutions regarding biomarkers in the immune system has also been driving the growth of the market. Manufacturers merging is also fueling the growth of the market. For example, Ambry Genetics and ArcherDX Inc. merged together to deliver immune repertoire sequencing services to customers of the biopharmaceutical. The immune repertoire sequencing market is segmented by product, by application, and by the end user. By product, the market is bifurcated into assay kits and software & services. The assay kits are further divided into TCR Kits and BCR Kits. Assay kit is expected to hold a major share of the market in the forecast period. TCR plays an essential role in the human adaptive immune system. It recalls, destructs and recognizes the pathogenic agents. Multiple companies are looking for merging in order to develop repertoire sequencing kits for immunotherapy response of a specific kind. For example, MIODx and DiaCarta collaborated together to develop MIODX's ClonoMapto predict the response of the patient to immunotherapy. On the basis of software & services, the market is bifurcated into analytical software, sequencing services, and data analysis services.

The end users of the market are infectious diseases, vaccine development, cancer immunotherapy, autoimmune disease, and transplant rejection & tolerance. Rising infectious diseases, advancement in vaccine development and research regarding cancer immunotherapy is expected to drive the growth of the market. In terms of region, North America is expected to hold a vast share of the market. Presence of a vast number of prominent players alongside growing attention towards novel technology for immune repertoire sequencing remains the key factor behind the growth of the market in the region. 10x Genomics Inc, a US-based company included 5'Unbiased Enrichment Kit to immune repertoire sequencing. Europe is expected to achieve the highest growth in the forecast period. The increased funding by the government alongside rising healthcare expenditure is expected to expand the size of the market in the region. Asia-Pacific region is also predicted to show immense growth of the market in the coming years. Rising health infrastructure in developing countries like China and Japan is also boosting the growth of the market in the region. Prominent players of the market are: ABVITRO (NOW JUNO THERAPEUTICS), ADAPTIVE BIOTECHNOLOGIES, AGILENT TECHNOLOGIES, ARCHERDX, INC., BGI, ILLUMINA, INC., IREPERTOIRE, INC., OXFORD NANOPORE TECHNOLOGIES, LTD, PACIFIC BIOSCIENCES, Qiagen N.V., Takara Bio Inc., CD Genomics, Roche Holding AG and Thermo Fisher Scientific Immune Repertoire Sequencing Market Segmentation: By Product Instrument

NGS

PCR

Assay, Kits and Reagent

TCR Kits

Human TCR Kits

Mouse TCR Kits

BCR Kits

Human BCR Kits

Mouse BCR Kits

Analytical Software

TCR Analysis Solutions

BCR Analysis Solutions

TCR & BCR Analysis Solutions

Services

Pre-Sequencing Services

Sequencing Services

Data Analysis Services By Application Biomarker Discovery

Autoimmune Diseases

Cancer Immunotherapy

Infectious Disease Research

Asthma and Allergy Research

Vaccine Development

Immunodeficiency Identification

Others (If Any) By End User Diagnostic Labs

Pharmaceutical and Biotech Companies

Research Institutes

Others (If Any) By Region North America

Europe

Asia-Pacific

Rest of the world Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share

• Tier 2 players

• Emerging players which are growing rapidly

• New Entrants FutureWise Takeaways:

• Growth prospects

• SWOT analysis

• Key trends

• Key data points affecting market growth Objectives of the Study:

• To provide with an exhaustive analysis on the immune repertoire sequencing market based on the products, application, end users and region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• To evaluate and forecast micro-markets and the overall market

• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

• Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement

The customization Mobility Care offered are free of charge with purchase of any license of the report

You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com